Bruker Corp.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.44B | $3.37B | $2.96B | $2.53B | $2.42B | $1.99B | $2.07B | $1.90B |
| Cost of Revenue | $1.86B | $1.72B | $1.45B | $1.23B | $1.21B | $1.05B | $1.08B | $995.6M |
| Gross Profit | $1.58B | $1.65B | $1.51B | $1.31B | $1.21B | $939.8M | $995.3M | $900.0M |
| Gross Margin | 45.9% | 49.0% | 51.0% | 51.6% | 50.0% | 47.3% | 48.0% | 47.5% |
| Operating Expenses | ||||||||
| Research & Development | $395.2M | $376.5M | $294.8M | $235.9M | $220.8M | $198.0M | $187.7M | $173.4M |
| SG&A Expense | $946.5M | $893.8M | $729.4M | $607.4M | $561.2M | $468.6M | $500.2M | $444.7M |
| Operating Income | $68.2M | $253.1M | $436.9M | $432.7M | $413.3M | $248.3M | $300.9M | $262.4M |
| Operating Margin | 2.0% | 7.5% | 14.7% | 17.1% | 17.1% | 12.5% | 14.5% | 13.8% |
| Interest Expense | — | $47.9M | $16.4M | $16.1M | $14.3M | $14.4M | $16.0M | $12.6M |
| Pretax Income | $22.0M | $206.9M | $544.2M | $413.9M | $393.6M | $225.8M | $280.4M | $244.7M |
| Income Tax Expense | $29.3M | $91.4M | $117.7M | $116.4M | $113.0M | $64.4M | $82.4M | $63.7M |
| Net Income | $-8.6M | $113.1M | $427.2M | $296.6M | $277.1M | $157.8M | $197.2M | $179.7M |
| Net Margin | -0.3% | 3.4% | 14.4% | 11.7% | 11.5% | 7.9% | 9.5% | 9.5% |
| EPS (Basic) | $-0.15 | $0.76 | $2.92 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $-0.15 | $0.76 | $2.90 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 151.8M | 149.0M | 146.4M | 146.4M | 149.2M | 151.14T | 152.91T | 153.90T |
| Shares Outstanding (Diluted) | 151.8M | 149.5M | 147.2M | 147.2M | 150.6M | 152.32T | 154.29T | 154.89T |
| Dividends Per Share | — | $0.20 | $0.20 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |